Immunoglobulin related amyloidosis presenting as isolated lymph node and pulmonary involvement

Leukemia and Lymphoma

Volumn 38, Issue 3-4, 2000, Pages 423-427

  Meeus, G ^a   Ponette, J ^a   Delabie, J ^a   Verschakelen, J ^a   Blockmans, D ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amyloidosis; Lymph nodes; Non Hodgkin lymphoma; Pulmonary

Indexed keywords

4' IODOESORUBICIN; IMMUNOGLOBULIN;

ADULT; AMYLOIDOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; CASE REPORT; HUMAN; LUNG DISEASE; LUNG INFILTRATE; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; PLEURA DISEASE; PRIORITY JOURNAL;

EID: 0034082713     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009087035     Document Type: Article

References (17)

1. Pascali E. (1995): Diagnosis and treatment of primary amyloidnsis. Critical reviews in oncology/hematology; 19: 149-181.
2. Nashitz J.E., Yeshurun D., Pick A.I. (1986): Intrathoracic amyloid lymphadenopathy. Respiration 49: 73-76.
3. Falk H.R., Comenzo R.L., Skinner M. (1997): The systemic amyloidoses. New England Journal of medicine; 13: 898-909.
4. Kahn H., Strauchen J., Gilbert H.S., Fuchs A. (1991): Immunoglobulin- related amyloidosis presenting as recurrent isolated lymph node involvement. Archives Pathology and Laboratory Medicine; 115: 948-950.
5. Newland JR, Linke RP, Kleinsasser O., Lennert K. (1983): Lymph node enlargement due to amyloid. Virchows Arch A.; 399: 233-236.
6. Laden A, Cohen M, Harley R (1984): Nodular pulmonary amyloidosis with extrapulmonary involvement. Human Pathology; 15: 594-597.
7. Dalton H.R., Featherstone T., Athanasou N. (1992): Organ limited amyloidosis with lymphadenopathy. Postgraduate Medicine Journal; 68: 47-50.
8. Desai R.A., Mahajan V, Benjamin S., Van Ortstrand M.S., Cordesco E.M. (1979): Pulmonary amyloidoma and hilar adenopathy. Chest; 76: 170-173.
9. Celli BR, Rubinow A, Cohen AS, Brody J.S. (1978): Patterns of pulmonary involvement in systemic amyloidosis. Chest; 74: 543-547.
10. Thompson PJ, Citreon KM (1983): Amyloid and the lower respiratory tract. Thorax; 38: 84-87.
11. Utz JP, Swensen SJ, Gertz MA (1996): Pulmonary amyloidosis. The Mayo clinic experience from 1980 to 1993. Annals of Internal Medicine; 124: 407-413.
12. Preud'homme JL, Caneval D. Grünfeld JP et al (1988): Immunoglobulin synthesis in primary and myeloma amyloidosis. Clinical and Experimental Immunology: 73: 389-394.
13. Kyle RA. (1984): "Benign" monoclonal gammopathy: A misnomer? Journal of the American Medicine Association; 251: 1849-1854.
14. Kyle RA. (1993): "Benign" monoclonal gammopathy after 20 to 35 years of follow-up. Mayo Clinic Proceedings,; 68: 26-36.
15. Kyle RA, Linos A, Beard C.M. et al (1992): Incidence and natural history of primary systemic amyloidosis in Olmstead County, Minnesota, 1950 through 1989. Blood; 79: 1817-1822.
16. Glenner GG. (1980): Amyloid deposits and amyloidosis. The β fibrilloses. New England Journal of Medicine; 302: 1283-1290.
17. Geusens E, Verschakelen JA, Bogaert JG (1997): Primary pulmonary amyloidosis as a cause of interlobular septal thickening. American Journal of Roentgenology; 168: 1116-1117.